Close
Back to SWTX Stock Lookup

SpringWorks Therapeutics Inc. (SWTX) – Hot Comments

May 27, 2022 07:46 AM UPDATE: Spring Works Therapeutics (SWTX) PT Lowered to $50 at Wedbush
May 27, 2022 07:44 AM JPMorgan Reiterates $92 PT on Spring Works Therapeutics (SWTX), 'we continue to see underappreciated fundamental value with nirogacestat in desmoid tumors and BCMA programs'

Back to SWTX Stock Lookup